Evidence map›Paper›PMID 32391659›Full record

ReviewZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2020

[Pharmaceutical care for severe and critically ill patients with COVID-19].

Saiping Jiang, Lu Li, Renping Ru, Chunhong Zhang, Yuefeng Rao, Bin Lin, Rongrong Wang, Na Chen, Xiaojuan Wang, Hongliu Cai and 4 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Saiping JiangThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Lu LiThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Renping RuHangzhou Xixi Hospital, Hangzhou 310023, China.
Chunhong ZhangThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China.
Yuefeng RaoThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Bin LinChangxing Hospital, the Second Affiliated Hospital, Zhejiang University School of Medicine, Changxing 313100, Zhejiang Province, China.
Rongrong WangThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Na ChenThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Xiaojuan WangThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Hongliu CaiThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Jifang ShengThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Jianying ZhouThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Xiaoyang LuThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Yunqing QiuThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
First Affiliated Hospital Zhejiang University · CNHangzhou Xixi hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe and critically ill patients with coronavirus disease 2019 (COVID-19) were usually with underlying diseases, which led to the problems of complicated drug use, potential drug-drug interactions and medication errors in special patients. Based on

Indexed as

Coronavirus InfectionsDrug TherapyPandemicsPneumonia, ViralAdrenal Cortex HormonesAnti-Bacterial AgentsAntiviral AgentsBetacoronavirusCOVID-19Critical IllnessHumansNutritional SupportProbioticsSARS-CoV-2Adrenal Cortex HormonesAnti-Bacterial AgentsAntiviral Agents

Identifiers

PMID32391659
PMCPMC8800720
OpenAlexW3012380820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.